DeepSeek’s recent claim that it can make artificial intelligence less power-hungry is just the latest reason the energy ...

In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...

The Centers for Medicare and Medicaid Services (CMS) has included Ozempic among the next 15 drugs chosen for Medicare negotiation. The CMS listed Ozempic, Rybelsus and Wegovy — all forms of ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...

Under the 2022 federal law, drugmakers must pay rebates ... scrutinized over the pricing of its blockbuster diabetes drug Ozempic and weight loss drug Wegovy. The company's top executive was ...

Robert F. Kennedy Jr., the nominee to lead the Department of Health and Human Services, made disputed claims before the ...

Interestingly, celebrities like Elon Musk, Oprah Winfrey and Amy Schumer, among others, have also endorsed drugs like Ozempic ...

Ozempic: Which Is Better for Weight Loss ... Tirzepatide has also been shown to be effective in those without diabetes. A 2022 study looked at more than 2,500 people with a BMI (body mass index ...

According to CMS data, Medicare Part D spending on Ozempic was more than $4.6 billion in 2022. Ozempic has become emblematic of the explosive enthusiasm for GLP-1 medications in the U.S. Danish ...

Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate ...

The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, ...

The negotiated prices of 15 Medicare Part D drugs, which include several blockbusters, will go into effect in 2027.